Blood Collection Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Blood Collection Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032


Global Blood Collection Market size is anticipated to grow at 6.9% CAGR between 2024 and 2032 due to the increasing prevalence of chronic diseases, rising demand for blood donations, and advancements in blood collection technologies. Reports indicate that approximately 1 in 3 adults grapples with multiple chronic conditions. The increasing prevalence of diseases like cancer, diabetes, and cardiovascular ailments boosts the demand for regular blood tests and diagnostics, subsequently driving the need for blood collection products. This trend underscores the importance of efficient healthcare solutions to manage chronic illnesses. Healthcare providers are investing in advanced blood collection technologies to meet this growing demand. With blood donation drives becoming increasingly organized and widespread, the demand for collection kits and accessories is on the rise. The expanding realm of diagnostic testing—especially with the surge in preventive healthcare, routine checkups, point-of-care testing, and home blood collection services—broadens the market horizons. These advancements ensure that blood collection processes are more accessible and efficient. The integration of digital health tools further enhances the accuracy and convenience of blood diagnostics. The industry categorizes itself based on product type, method, application, end-user, and region. From 2024 to 2032, the capillary segment of the blood collection market is set to expand, driven by its convenience and efficiency in gathering small blood samples. This is especially true for point-of-care testing and pediatric applications. Methods like fingerstick and heelstick provide less invasive alternatives to traditional venipuncture, making them suitable for routine tests, glucose monitoring, and screenings for newborns. These methods also reduce patient discomfort and improve compliance with testing protocols. From the treatment application segment, the blood collection industry is poised for significant growth. This surge is driven by the increasing demand for precise and timely diagnostics in managing both chronic and acute medical conditions. As treatment protocols for ailments like cancer, diabetes, and infectious diseases grow more intricate, the necessity for frequent and accurate blood testing becomes paramount for monitoring patient progress and customizing therapies. Enhanced diagnostic capabilities are crucial for early detection and effective disease management. Asia Pacific blood collection industry is projected to see substantial growth through 2024-2032. This is attributed to an expanding healthcare infrastructure, increasing prevalence of chronic diseases, and rising awareness about early diagnosis and preventive healthcare. Rapid urbanization and economic development are leading to greater investment in healthcare facilities and technologies, including advanced blood collection systems. Governments in the region are also implementing policies to improve healthcare access and quality.


Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic and infectious diseases
3.2.1.2 Advancements in blood collection technologies
3.2.1.3 Increasing number of surgical procedures
3.2.1.4 Rising geriatric population
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of blood collection equipment
3.2.2.2 Risks associated with blood transfusions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Venous
5.2.1 Needles and syringes
5.2.1.1 Double-ended needles
5.2.1.2 Winged blood collection sets
5.2.1.3 Standard hypodermic needles
5.2.1.4 Other blood collection needles
5.2.2 Blood collection tubes
5.2.2.1 Serum-separating
5.2.2.2 EDTA
5.2.2.3 Heparin
5.2.2.4 Plasma-separating
5.2.3 Blood bags
5.2.4 Other venous products
5.3 Capillary
5.3.1 Lancets
5.3.2 Micro-container tubes
5.3.3 Micro-hematocrit tubes
5.3.4 Warming devices
5.3.5 Other capillary products
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Manual blood collection
6.3 Automated blood collection
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Diagnostics
7.3 Treatment
7.4 Research
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic centers
8.4 Blood banks
8.5 Academic and research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 Cardinal Health, Inc.
10.4 F. Hoffmann-La Roche Ltd.
10.5 FL MEDICAL s.r.l.
10.6 Fresenius SE and Co. KGaA
10.7 Haemonetics Corporation
10.8 Greiner AG
10.9 McKESSON CORPORATION
10.10 Medtronic plc
10.11 Nipro Corporation
10.12 QIAGEN N.V.
10.13 Sarstedt AG and Co. KG
10.14 Siemens Healthineers AG
10.15 Terumo Corporation
10.16 Thermo Fisher Scientific Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings